Deinove

Latest news

18.09.2019

The efficacy of Hebelys® once again demonstrated and promoted in the International Journal of Cosmetic Science

New in vitro and clinical efficacy data have been published; Sphingomonas hydrophobicum extract,...

09.07.2019

Issuance of notes convertible into new shares for a maximum amount of €15M. Issuance of a first €2.2 million tranche

DEINOVE (Euronext Growth Paris: ALDEI), a French biotech company that uses a disruptive approach to...

More press releases

Antibiotic resistance, a global health challenge

The development of antibiotic resistance is, according to international organizations and governments, one of the major health challenges of the 21st century

More info

In the Medias

19.06.2019

DEINOVE among The Top 20 Industrial Biotechnology Companies in Europe

Europe’s industrial biotechnology sector is driving a massive change from petrochemical processes to more sustainable alternatives. Here...

14.06.2019

Formule Verte | Deinove et Avril avancent sur leur nouvelle gamme d’ingrédients

La société de biotechnologies industrielles Deinove et Avril, l’acteur industriel et financier des filières des huiles et des protéines,...

More press coverage

Disruptive innovation

Latest news

Antibiotic resistance, a global health challenge

In the Medias